Avastin® (bevacizumab) Clinical Trials | NSCLC Treatment
Main clinical trials of bevacizumab in previously-untreated patients... | Download Table
BEVACIZUMAB IN OVARIAN CANCER: Phase III Trial -Clinical Trials Ongoing | Download Table
PLOS ONE: Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial - Clinical Therapeutics
Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials - Journal of Hepatology
Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non–small cell lung cancer - The Journal of Thoracic and Cardiovascular Surgery
A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer - Gynecologic Oncology
Publication of the final data from the clinical trial for mAbxience bevacizumab in metastatic colorectal cancer published in The Lancet Gastroenterology & Hepatology
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook - Cancer Treatment Reviews
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer - Annals of Oncology
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Bevacizumab beyond first disease progression in metastatic colorectal cancer: a review of recent clinical trial data | Colorectal Cancer
.jpg?$pp-text-image$ "Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix (ENGOT-Cx10 / GEICO 68-C / JGOG1084 / GOG-3030 / BEATcc)")
Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix (ENGOT-Cx10 / GEICO 68-C / JGOG1084 / GOG-3030 / BEATcc)
Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial | PLOS ONE
A New Day Dawns For Avastin I Pharma Intelligence
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Efficacy and tolerability of bevacizumab in patients with severe Covid-19 | Nature Communications
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group -
Bevacizumab for Cancer Clinical Trial | Power
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
Avastin Full Prescribing Information, Dosage & Side Effects | MIMS Malaysia
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial - The Lancet Oncology
Bevacizumab Biosimilar Market Opportunity, Sales, Price & Clinical Trials Insight 2025
Grpahical Abstract - The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer
Cancer, HHT and Avastin: What's the Connection? - CureHHT
![PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f15aa00fe070d53cbd782ae6153a6a322dec4f1/4-Figure2-1.png "PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar")